Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Omecamtiv Mecarbil in Stable Heart Failure
NCT00624442Phase 2Completed
- Sponsor
- Cytokinetics
- Start
- Apr 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of omecamtiv mecarbil in heart failure (HF), sponsored by Cytokinetics. Started Apr 2007; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00624442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624442.